Biblio

Author Title [ Type

] Year

Filters: Author is Giammarco, Sabrina [Clear All Filters]

Journal Article

Metafuni E, Cavattoni IMaria, Lamparelli T, Raiola AMaria, Ghiso A, Galaverna F, Gualandi F, Di Grazia C, Dominietto A, Varaldo R, et al. Day100 Score predicts moderate-severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation. Blood Adv. 2021.

Metafuni E, Giammarco S, Bellesi S, Rossi M, Minnella G, Limongiello MAssunta, Valentini CGiovanna, Teofili L, Sica S, Chiusolo P. Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant. Int J Lab Hematol. 2023.

Chiusolo P, Bregante S, Giammarco S, Lamparelli T, Casarino L, Dominietto A, Raiola AMaria, Metafuni E, Di Grazia C, Gualandi F, et al. Full Donor Chimerism After Allogeneic Hematopoietic Stem Cells Transplant For Myelofibrosis: The Role Of The Conditioning Regimen. Am J Hematol. 2020.

Giammarco S, Sica S, Metafuni E, Limongiello MAssunta, Valentini CGiovanna, Sorà F, Marra JDonald, Bacigalupo A, Teofili L, Chiusolo P. Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center. Transfus Apher Sci. 2023:103708.

Viscovo M, Metafuni E, Giammarco S, Santopaolo F, Frioni F, Pellegrino C, Sica S, Chiusolo P, Pompili M. Late HBV reactivation after hematopoietic stem cell transplantation, despite long-term prophylaxis. Eur J Clin Microbiol Infect Dis. 2023.

Piccirillo N, Putzulu R, Metafuni E, Massini G, Fatone F, Corbingi A, Giammarco S, Limongiello MAssunta, Di Giovanni A, Zini G, et al. Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization?. Transfus Med Rev. 2023;37(2):150725.

Griffin M, Eikema D-J, Verheggen I, Kulagin A, Tjon JM-L, Fattizzo B, Ingram W, Zaidi U, Desnica L, Giammarco S, et al. SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria. Haematologica. 2023.